Synthego

10 articles about Synthego

• Synthego Announces Invalidation of Agilent Patents in CRISPR Dispute

  5/17/2023

  Synthego Corp. has announced a victory in its dispute with Agilent Technologies, Inc., regarding two of Agilent's patents which have been invalidated by a ruling of the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office.

• Synthego Opens State-of-the-Art GMP Guide RNA Manufacturing Facility to Enable CRISPR Genomic Medicines

  5/11/2023

  Synthego Corp., a leading provider of genome engineering solutions, announced the opening of its state-of-the-art GMP synthesis facility.

• Synthego Introduces CRISPR Discovery Partners to Streamline CRISPR-Driven Drug Discovery Research

  3/16/2023

  Synthego Corp. announced the launch of its service partner ecosystem, CRISPR Discovery Partners, designed to accelerate drug discovery by providing a seamless research workflow from CRISPR editing to phenotypic data and downstream services.

• 

  Calibr, Synthego, BlueSphere and More Showcase Data at CAR-TCR Summit

  9/22/2022

  The 7th Annual CAR-TCR Summit is ongoing in Boston, with more than 1,000 experts in CAR and TCR technologies attending. Here’s a look at some of the latest research and data being presented.

• Synthego Launches Engineered Cell Libraries to Validate Targets with Speed and Accelerate Drug Discovery

  8/2/2022

  Synthego, the genome engineering company, announced the launch of Engineered Cell Libraries, a novel offering that further enables access to CRISPR by providing arrayed CRISPR-edited cells for direct use in functional screening assays.

• Synthego Expands Capabilities of Halo Platform with Next-Generation Manufacturing Facility

  7/26/2022

  Synthego, the genome engineering company, announced that the company has broken ground on a 20,000-square-foot manufacturing facility designed to accelerate translational and clinical research development timelines for cell and gene therapies to as little as a year.

• 

  Money on the Move: February 16–22

  2/23/2022

  More biotech companies turn to private investors as the market churns volatile for life sciences. Here’s who’s scooping up the cash this week.
• 

  BioSpace Movers & Shakers, Feb. 18

  2/18/2022

  Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.

• Synthego Raises $200 Million to Accelerate the Field of CRISPR-Based Medicines from Early-phase Research to the Clinic

  2/17/2022

  Synthego, the genome engineering company, today announced it has raised $200 million of growth capital, including a Series E financing led by Perceptive Advisors.

• 

  Synthego Scores $200M to Advance CRISPR “Science at Scale”

  2/17/2022

  The company plans to use the monies raised to create a cell and gene therapy discovery and development ecosystem researchers can use to speed their research.